Pilot study of H<sub>2</sub> therapy in Parkinson's disease: A randomized double‐blind placebo‐controlled trial

2013157 citationsJournal Article

Authors

Asako Yoritaka · Juntendo University

Masashi Takanashi · Juntendo University

Masaaki Hirayama · Nagoya University

Toshiki Nakahara · Juntendo University

Shigeo Ohta · Nippon Medical School

Nobutaka Hattori · Juntendo University

Abstract

The results indicated that drinking H₂-water was safe and well tolerated, and a significant improvement in total UPDRS scores for patients in the H₂-water group was demonstrated.

Topics & Keywords

Hydrogen's biological and therapeutic effects

UN Sustainable Development Goals

Clean water and sanitation

Publication Details

Published in: Movement Disorders

Volume 28, Issue 6, pp. 836-839

DOI: 10.1002/mds.25375

Field-Weighted Citation Impact: 8.71